Bonniaud G, Isambert A, Dhermain F, Beaudré A, Ferreira I, Ricard M, Lefkopoulos D
Service de physique médicale, institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif, France.
Cancer Radiother. 2006 Sep;10(5):222-30. doi: 10.1016/j.canrad.2006.06.006. Epub 2006 Aug 4.
The development of conformal radiotherapy techniques (CRT) and intensity modulated CRT requires an accurate delineation of target structures and organs at risk. Thus, additional information provided by anatomical and/or functional imaging modalities can be used for volume of interest determination combined with traditionally used Computed Tomography imaging (CT): for instance, functional or morphological Magnetic Resonance Imaging (f MRI or m MRI) or Positron Emission Tomography (PET). A prerequisite to the simultaneous use of this information is image registration. Due to the differences between the images and the information they provide, a quality control of image registration process for radiotherapy is mandatory. The purpose of this article is to present the difficulties in implementing such controls and to show the necessity for a clinical validation on patient's images. The last part of this work presents the possible interest in using f MRI to help radio-oncologists in the treatment planning for gliomas associated to image coregistration and quality control considerations.
适形放射治疗技术(CRT)和调强CRT的发展需要精确勾勒靶区结构和危及器官。因此,解剖学和/或功能成像模态提供的额外信息可与传统使用的计算机断层扫描成像(CT)相结合用于感兴趣体积的确定:例如,功能或形态磁共振成像(f MRI或m MRI)或正电子发射断层扫描(PET)。同时使用这些信息的一个前提是图像配准。由于图像及其提供的信息之间存在差异,放疗图像配准过程的质量控制是必不可少的。本文的目的是阐述实施此类控制的困难,并表明对患者图像进行临床验证的必要性。这项工作的最后一部分介绍了使用f MRI帮助放射肿瘤学家进行与图像配准和质量控制考虑相关的胶质瘤治疗计划的潜在意义。